Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ampio Pharmaceuticals Inc (NYSE American:AMPE)

1.68
Delayed Data
As of Dec 12
 +0.07 / +4.35%
Today’s Change
0.38
Today|||52-Week Range
2.20
+86.63%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$106.3M

Company Description

Ampio Pharmaceuticals, Inc. is a biopharmaceutical company, that engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation, sexual dysfunction and CNS disease. The company was founded by David Bar-Or in April 2010 and is headquartered in Greenwood Village, CO.

Contact Information

Ampio Pharmaceuticals, Inc.
373 Inverness Parkway
Englewood Colorado 80112
P:(720) 437-6500
Investor Relations:

Employees

Shareholders

Individual stakeholders7.59%
Mutual fund holders2.32%
Other institutional12.32%

Top Executives

Michael MacalusoChairman & Chief Executive Officer
Holli CherevkaChief Operating Officer
Thomas E. ChilcottChief Financial Officer & Secretary
David Bar-OrDirector & Chief Scientific Officer